Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
Study NCT ID:
NCT03425760
Status:
COMPLETED
Last Update Posted:
2018-06-29
First Post:
2018-01-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Cross-sectional Study of COPD and Symptom Variability in MEA Countries
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
A Cross-sectional Study of COPD and Symptom Variability in MEA Countries
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COPVAR
Brief Summary:
This non-interventional study aims at assessing stable GOLD C and D COPD patient's perception of daily and weekly symptoms variability and their impact on daily activities.
It will also explore the current practice in management of stable GOLD C and D COPD patients.
It will also explore the current practice in management of stable GOLD C and D COPD patients.
Detailed Description:
1. Primary objective: To assess perception of daily and weekly variability of symptoms in stable GOLD C and D COPD patients and their impact on daily life activities
2. Secondary objectives:
* To describe the current treatment practice for the management of GOLD C and D COPD in MEA countries and their adherence to the GOLD 2015 guidelines
* To compare patients' perception of symptoms variability and their impact on activities between Gold categories C and D
* To identify demographic, behavioral and clinical factors associated with symptoms variability.
2. Secondary objectives:
* To describe the current treatment practice for the management of GOLD C and D COPD in MEA countries and their adherence to the GOLD 2015 guidelines
* To compare patients' perception of symptoms variability and their impact on activities between Gold categories C and D
* To identify demographic, behavioral and clinical factors associated with symptoms variability.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: